![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Imielinski Marcin Hakonarson Hakon
Publisher: Future Medicine
ISSN: 1462-2416
Source: Pharmacogenomics, Vol.11, Iss.5, 2010-05, pp. : 663-665
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Insight from genome-wide association studies into coronary heart disease
By Hoffmann Michael M Renner Wilfried
Pharmacogenomics, Vol. 13, Iss. 4, 2012-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Meta-analysis in genome-wide association studies
By Zeggini Eleftheria Ioannidis John PA
Pharmacogenomics, Vol. 10, Iss. 2, 2009-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ask the Experts: Pharmacogenomics and genome-wide association studies
Pharmacogenomics, Vol. 14, Iss. 4, 2013-03 ,pp. :